Global Health recommends two new drugs to treat corona
The World Health Organization has recommended two new medicines for Chas suggests two novel treatments for Covid-19.
contribute to relieving the severity of symptoms and reducing the chances of death from the virus.
It is recommended by the World Health Organization that it be given alongside corticosteroids.
The organization also recommended one of the monoclonal antibody drugs, Sotrovimab, for the treatment of mild and moderate cases, and those who are most likely to be hospitalized due to the Coronavirus, such as patients with low immunity, the elderly, patients with high blood pressure and diabetes, or patients who have not received the COVID-19 vaccine.
Although studies are still ongoing to determine the effectiveness of monoclonal antibody drugs against the Omicron mutant, the initial results are promising and lead to significant efficacy.
On the other hand, the World Health Organization made a conditional recommendation not to use Ruxolitinib and Tofacitinib due to their uncertain effects. Based on evidence from 7 trials involving more than 4,000 patients with non-serious, severe, and critical cases of the corona.
It must be noted that the organization is currently in discussion with the manufacturers of the previous medicines that it recommended, regarding supplying them globally and ensuring fair and equal access to them throughout the world.
Comments
Post a Comment